AbbVie M16-904
Leuprolide acetate

Type of Study:
Interventional

Study Length:
up to 3 years

Target Age/Sex:
2 – 11 years of age, Male and Female

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures and compensation for time

Link: ClinicalTrials.gov

Staus: On Hold

Description:

To evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of Leuprolide Acetate 45 mg 6-month depot formulation in children with Central precocious puberty

This Study is On Hold.